Sofinnova Investments’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Sofinnova Investments's UTHR Position: Q3 2026 in Review
Sofinnova Investments reduced its United Therapeutics (UTHR) stake by 52% in Q3 2026, selling an estimated $20.7M and leaving 36,491 shares worth $19.8M. The position accounts for 0.86% of the portfolio, ranked #26.
Sofinnova Investments first reported a position in UTHR in Q3 2019 and has held it in 20 quarters since. The position peaked at $94.9M in Q1 2026. 848 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Sofinnova Investments held 36,491 shares of United Therapeutics worth $19.8M as of Q3 2026.
- Sofinnova Investments sold 39,998 United Therapeutics shares in Q3 2026, an estimated $20.7M.
- United Therapeutics made up 0.86% of Sofinnova Investments's portfolio in Q3 2026, its #26 holding.
- Sofinnova Investments first reported a position in United Therapeutics in Q3 2019 and has held it in 20 quarters since.
- Sofinnova Investments's United Therapeutics position peaked at $94.9M in Q1 2026.
- 848 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Sofinnova Investments's 13F filing for Q3 2026, filed 16 Nov 2026.